Cheryl Abrahamian leads the Audit & Inspection Management (AIM) organization for the Americas at Fortrea. She brings more than 13 years with Fortrea and over 28 years of experience in GCP quality assurance and auditing across the pharmaceutical and medical device clinical research industries in the United States and Canada.

Cheryl began her career in the medical device sector, supporting CE Mark attainment, ISO 9001 certification, Medical Device Directive compliance, and FDA Premarket Approval submission. She also completed formal training as an ISO 9001 certified auditor. Her career later shifted toward Good Clinical Practice (GCP) within the CRO environment, where she spent several years auditing during periods of significant organizational growth, acquisitions, and industry transformation.

Cheryl joined legacy Chiltern International as a GCP auditor and progressed into leadership roles, ultimately assuming responsibility for the AIM function across the Americas at Fortrea. Throughout her career and tenure at Fortrea, she has led and supported multiple successful FDA regulatory inspections of the company and contributed to numerous sponsor and clinical investigator site regulatory inspections. These experiences have strengthened her ability to collaborate effectively across functions, build strong partnerships, and expand strategic relationships throughout the organization.

She holds a Bachelor of Science in Education with a minor in Sociology from Fitchburg State University and has maintained her credential as a Registered Quality Assurance Professional in Good Clinical Practice (RQAP‑GCP) through the Society of Quality Assurance (SQA) since 2008.

Based near Atlanta, Georgia, Cheryl is recognized as a trusted leader committed to fostering strong relationships within Quality Assurance, across global teams, and throughout the broader business and industry landscape.